Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients

NCT06007586 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

143

Enrollment

OTHER

Sponsor class

Conditions

Gynecological Tumor
Ovarian Cancer
Cervical Cancer
Endometrial Cancer
Fallopian Tube Cancer

Interventions

DRUG: Aprepitant Injection

Sponsor

Sichuan Cancer Hospital and Research Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]